Company intelligence

HELP

Price—Latest market price

Market cap—Equity value

P / E—Trailing ratio

Volume—Latest session

Market data

HELP price chart

TradingView

Related signals

1 min delayed

Browse public HELP signals with their source context and measured market impact. Open any signal for its permanent analysis page.

HELPMar 5, 2026-4.63% since signal

Helus Pharma Shares Fall Despite Ph II Results Announcement for HLP004

Helus Pharma's shares fell sharply after announcing topline results from the Phase 2 study of HLP004, a treatment for generalized anxiety disorder. The market response suggests disappointment, which may affect investor sentiment and future stock performance.

View signal analysis

Research